MEPED as salvage therapy for relapsed/refractory Hodgkin’s lymphoma incorporating edited non-oncogene addiction: mTOR as a bottleneck - Harrer, Dennis Christoph; Lüke, Florian; Pukrop, Tobias; Ghibelli, Lina; Reichle, Albrecht; Heudobler, Daniel (Frontiers in Pharmacology, 2025)